|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.245 EUR | -0.66% |
|
+6.88% | -7.54% |
| Jan. 20 | BRAIN Biotech AG, 2025 Earnings Call, Jan 14, 2026 | |
| Jan. 14 | BRAIN Biotech AG Provides Revenue Guidance for the Year 2025/2026 | CI |
Projected Income Statement: BRAIN Biotech AG
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 38.4 | 49.5 | 55.34 | 54.6 | 49.62 | 56.97 | 66.57 | 64.26 |
| Change | - | 28.91% | 11.79% | -1.33% | -9.12% | 14.81% | 16.84% | -3.47% |
| EBITDA 1 | -2.5 | -1.309 | -0.826 | -4 | -2.025 | 3.12 | 14.2 | - |
| Change | - | 47.64% | 36.9% | -384.26% | 49.38% | 254.07% | 355.29% | - |
| EBIT 1 | -6.548 | -5.648 | -5.48 | -8.852 | -7.151 | -3.549 | 2.496 | 0.7285 |
| Change | - | 13.74% | 2.97% | -61.53% | 19.22% | 50.37% | 170.33% | -70.81% |
| Interest Paid 1 | -0.727 | -1.696 | -1.307 | -2.035 | -5.989 | -3.7 | -4.2 | - |
| Earnings before Tax (EBT) 1 | -4.276 | -6.165 | -7.489 | -10.99 | -12.02 | -7.318 | -1.249 | -6.524 |
| Change | - | -44.18% | -21.48% | -46.75% | -9.4% | 39.13% | 82.94% | -422.47% |
| Net income 1 | -4.972 | -6.59 | -8.279 | -11.13 | -11.74 | -6.808 | -1.628 | -5.44 |
| Change | - | -32.54% | -25.63% | -34.4% | -5.53% | 42.02% | 76.09% | -234.15% |
| Announcement Date | 1/17/22 | 1/16/23 | 1/17/24 | 1/15/25 | 1/14/26 | - | - | - |
1EUR in Million
Estimates
Forecast Balance Sheet: BRAIN Biotech AG
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | -3.7 | 15.4 | 23.5 | 9.26 | 17.6 | 24.1 | 27.8 | 31.8 |
| Change | - | 516.22% | 52.6% | -60.6% | 90.06% | 37.29% | 15.35% | 14.39% |
| Announcement Date | 1/17/22 | 1/16/23 | 1/17/24 | 1/15/25 | 1/14/26 | - | - | - |
1EUR in Million
Estimates
Cash Flow Forecast: BRAIN Biotech AG
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 1.262 | 6.082 | 2.619 | 1.552 | 1.532 | 3.1 | 3.55 | 3.5 |
| Change | - | 381.93% | -56.94% | -40.74% | -1.29% | 102.35% | 14.52% | -1.41% |
| Free Cash Flow (FCF) 1 | -5.168 | -7.567 | -6.856 | -5.312 | -10.76 | -8.1 | -7.3 | - |
| Change | - | -46.42% | 9.4% | 22.52% | -102.65% | 24.76% | 9.88% | 100% |
| Announcement Date | 1/17/22 | 1/16/23 | 1/17/24 | 1/15/25 | 1/14/26 | - | - | - |
1EUR in Million
Estimates
Forecast Financial Ratios: BRAIN Biotech AG
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
| EBITDA Margin (%) | -6.51% | -2.64% | -1.49% | -7.33% | -4.08% | 5.48% | 21.34% | - |
| EBIT Margin (%) | -17.05% | -11.41% | -9.9% | -16.21% | -14.41% | -6.23% | 3.75% | 1.13% |
| EBT Margin (%) | -11.14% | -12.45% | -13.53% | -20.13% | -24.23% | -12.85% | -1.88% | -10.15% |
| Net margin (%) | -12.95% | -13.31% | -14.96% | -20.38% | -23.66% | -11.95% | -2.45% | -8.47% |
| FCF margin (%) | -13.46% | -15.29% | -12.39% | -9.73% | -21.69% | -14.22% | -10.97% | - |
| FCF / Net Income (%) | 103.94% | 114.83% | 82.81% | 47.74% | 91.68% | 118.97% | 448.36% | - |
Profitability | ||||||||
| ROA | -6.63% | -8.46% | -11.12% | -13.94% | -15.14% | -15.78% | -13.86% | -9.91% |
| ROE | -16.69% | -19.26% | -32.21% | -62.89% | -162.44% | - | - | - |
Financial Health | ||||||||
| Leverage (Debt/EBITDA) | - | -11.79x | -28.42x | -2.31x | -8.67x | 7.71x | 1.96x | - |
| Debt / Free cash flow | - | -2.04x | -3.42x | -1.74x | -1.63x | -2.97x | -3.81x | - |
Capital Intensity | ||||||||
| CAPEX / Current Assets (%) | 3.29% | 12.29% | 4.73% | 2.84% | 3.09% | 5.44% | 5.33% | 5.45% |
| CAPEX / EBITDA (%) | -50.48% | -464.63% | -317.07% | -38.8% | -75.65% | 99.36% | 24.99% | - |
| CAPEX / FCF (%) | -24.42% | -80.38% | -38.2% | -29.22% | -14.23% | -38.27% | -48.63% | - |
Items per share | ||||||||
| Cash flow per share 1 | -0.1959 | -0.068 | -0.1931 | -0.164 | -0.4226 | -0.0351 | 0.00802 | -0.0517 |
| Change | - | 65.3% | -184.1% | 15.07% | -157.68% | 91.69% | 122.85% | -744.64% |
| Dividend per Share 1 | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - |
| Book Value Per Share 1 | 1.775 | 1.357 | 0.9965 | 0.5775 | 0.0842 | -0.1244 | -0.1941 | -0.9826 |
| Change | - | -23.58% | -26.54% | -42.05% | -85.42% | -247.7% | -56.06% | -406.29% |
| EPS 1 | -0.25 | -0.3 | -0.38 | -0.51 | -0.54 | -0.3128 | -0.0729 | -0.249 |
| Change | - | -20% | -26.67% | -34.21% | -5.88% | 42.08% | 76.7% | -241.73% |
| Nbr of stocks (in thousands) | 21,847 | 21,847 | 21,847 | 21,847 | 21,847 | 21,847 | 21,847 | 21,847 |
| Announcement Date | 1/17/22 | 1/16/23 | 1/17/24 | 1/15/25 | 1/14/26 | - | - | - |
1EUR
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E ratio | -7.23x | -31x |
| PBR | -18.2x | -11.6x |
| EV / Sales | 1.29x | 1.16x |
| Yield | - | - |
EPS & Dividend
Y-o-Y evolution of P/E
Year-on-year evolution of the Yield
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.260EUR
Average target price
5.425EUR
Spread / Average Target
+140.04%
Annual profits - Rate of surprise
- Stock Market
- Equities
- BNN Stock
- Financials BRAIN Biotech AG
Select your edition
All financial news and data tailored to specific country editions
